Financhill
Back

Xeris Biopharma Holdings Quote, Financials, Valuation and Earnings

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!
Buy
69

XERS
Xeris Biopharma Holdings

Last Price:
1.88
Seasonality Move:
-5.66%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Xeris Biopharma Holdings Price Quote

$1.88
-0.01 (1.08%)
(Updated: May 4, 2024 at 6:45 AM ET)

Xeris Biopharma Holdings Key Stats

Buy
69
Xeris Biopharma Holdings (XERS) is a Buy

Day range:
$1.84 - $1.93
52-week range:
$1.46 - $3.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.58
P/B ratio:
0%

Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-18.18%
Market cap:
$278.7M
Revenue:
$163.9M
EPS:
$-0.44

How Much Does Xeris Biopharma Holdings Make?

Is Xeris Biopharma Holdings Growing As A Company?

Xeris Biopharma Holdings Stock Price Performance

What Is Xeris Biopharma Holdings 52-Week High & Low?

Xeris Biopharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xeris Biopharma Holdings?

Is Xeris Biopharma Holdings Cash Flow Positive?

  • What Is XERS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$47M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.6M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6M

Xeris Biopharma Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    XERS return on invested capital is -30.22%
  • What Is Xeris Biopharma Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -18.92%
  • What Is XERS Return On Equity?
    ROE is a measure of profitability and is -362.12%

Xeris Biopharma Holdings Earnings Date & Stock Price

Xeris Biopharma Holdings Competitors

Xeris Biopharma Holdings Dividend Yield

Data Unavailable

Xeris Biopharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -11.11%
Revenue: 33.93% 3.95%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.75
Upside from Last Price: 151.32%

Major Shareholders

  • How many XERS shares are owned by institutional investors?
    81.4M XERS shares are owned by institutional investors
  • How many XERS shares are owned by insiders?
    11.9M XERS shares are owned by insiders